Iterum Therapeutics PLC

NASDAQ ITRM

Download Data

Iterum Therapeutics PLC Operating Income Per Share for the quarter ending March 31, 2024: -0.40

Iterum Therapeutics PLC Operating Income Per Share is -0.40 for the quarter ending March 31, 2024, a 40.63% change year over year. Operating income per share represents the amount of operating income generated by a company per outstanding share. It is calculated by dividing the operating income by the weighted average number of basic shares outstanding. This metric provides insights into the company's profitability from its core operations on a per-share basis. It is useful for evaluating the company's operational performance and comparing it with other companies on a per-share basis.
  • Iterum Therapeutics PLC Operating Income Per Share for the quarter ending March 31, 2023 was -0.67, a -11.24% change year over year.
  • Iterum Therapeutics PLC Operating Income Per Share for the quarter ending March 31, 2022 was -0.60, a 16.20% change year over year.
  • Iterum Therapeutics PLC Operating Income Per Share for the quarter ending March 31, 2021 was -0.72, a 94.45% change year over year.
  • Iterum Therapeutics PLC Operating Income Per Share for the quarter ending March 31, 2020 was -13.01, a 39.45% change year over year.
NASDAQ: ITRM

Iterum Therapeutics PLC

CEO Mr. Corey N. Fishman
IPO Date May 25, 2018
Location Ireland
Headquarters Fitzwilliam Court, Dublin, Ireland, 2
Employees 14
Sector Healthcare
Industry Biotechnology
Description

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Similar companies

HOTH

Hoth Therapeutics Inc

NA

NA

StockViz Staff

September 16, 2024

Any question? Send us an email